The sympathetic nervous system and blood pressure in humans: implications for hypertension

被引:0
作者
J P Fisher
J F R Paton
机构
[1] School of Sport and Exercise Sciences,
[2] College of Life & Environmental Sciences,undefined
[3] University of Birmingham,undefined
[4] School of Physiology & Pharmacology,undefined
[5] Bristol Heart Institute,undefined
[6] Medical Sciences Building,undefined
[7] University of Bristol,undefined
来源
Journal of Human Hypertension | 2012年 / 26卷
关键词
sympathetic nerve activity; neurogenic hypertension; immune-to-brain signalling;
D O I
暂无
中图分类号
学科分类号
摘要
A neurogenic component to primary hypertension (hypertension) is now well established. Along with raised vasomotor tone and increased cardiac output, the chronic activation of the sympathetic nervous system in hypertension has a diverse range of pathophysiological consequences independent of any increase in blood pressure. This review provides a perspective on the actions and interactions of angiotensin II, inflammation and vascular dysfunction/brain hypoperfusion in the pathogenesis and progression of neurogenic hypertension. The optimisation of current treatment strategies and the exciting recent developments in the therapeutic targeting of the sympathetic nervous system to control hypertension (for example, catheter-based renal denervation and carotid baroreceptor stimulation) will be outlined.
引用
收藏
页码:463 / 475
页数:12
相关论文
共 628 条
[1]  
Carretero OA(2000)Essential hypertension. Part I: definition and etiology Circulation 101 329-335
[2]  
Oparil S(2010)The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management J Appl Physiol 108 227-237
[3]  
Esler M(2010)Point: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension J Appl Physiol 109 1996-1998
[4]  
Esler M(1982)Physiological aspects of primary hypertension Physiol Rev 62 347-504
[5]  
Lambert E(2010)Counterpoint: activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension J Appl Physiol 109 1998-2000
[6]  
Schlaich M(1989)Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings Hypertension 14 177-183
[7]  
Folkow B(2009)Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J Physiol 587 597-610
[8]  
Navar LG(2002)Sympathetic neural mechanisms in white-coat hypertension J Am Coll Cardiol 40 126-132
[9]  
Anderson EA(2004)Relationship between central sympathetic activity and stages of human hypertension Am J Hypertens 17 217-222
[10]  
Sinkey CA(1953)Sympathectomy in the treatment of hypertension; review of 122 cases Lancet 1 403-408